Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
Add more filters










Publication year range
1.
J Matern Fetal Neonatal Med ; 37(1): 2355293, 2024 Dec.
Article in English | MEDLINE | ID: mdl-38873894

ABSTRACT

BACKGROUND: Extracorporeal membrane oxygenation (ECMO) use in peripartum patients is rare, and there is a gap in the literature on the outcomes and guidance on using ECMO in peripartum patients. This study describes ECMO strategies our institution uses for peripartum patients and reports outcomes of ECMO use in peripartum patients with respiratory and/or cardiac failure. METHODS: A case series of all peripartum patients, defined as pregnant or up to 6 weeks after delivery of an infant >20 weeks gestation, from 2018 to 2023 from a single center requiring ECMO support. Patients were included if ECMO was initiated in the setting of cardiac, pulmonary, or combined failure. Patient demographics, operative details, ECMO data, and adverse outcomes for maternal, fetus, and neonates were all collected. RESULTS: Eighteen patients met the inclusion criteria. The cohort had a mean maternal age of 30.7 years old and was racially diverse. A majority of this cohort tested positive for COVID-19 (n = 10, 55%). ECMO was a bridge to recovery for all patients, of whom 14 (78%) were discharged out of the hospital alive. No patients received transplantation or a durable mechanical device. The most common complications were infection (25%) and postpartum hemorrhage (22%). CONCLUSIONS: ECMO use in peripartum patients in a single tertiary center was associated with a high survival rate. Furthermore, a strong multidisciplinary team, careful reevaluation of clinical trajectory, and consideration of complications and risks associated with using ECMO in peripartum patients are possible frameworks to use when challenged with critically ill peripartum patients.


Subject(s)
COVID-19 , Extracorporeal Membrane Oxygenation , Peripartum Period , Humans , Extracorporeal Membrane Oxygenation/methods , Extracorporeal Membrane Oxygenation/statistics & numerical data , Female , Pregnancy , Adult , COVID-19/therapy , COVID-19/complications , Retrospective Studies , Infant, Newborn , SARS-CoV-2 , Respiratory Insufficiency/therapy , Heart Failure/therapy , Young Adult
2.
J Surg Case Rep ; 2023(6): rjad246, 2023 Jun.
Article in English | MEDLINE | ID: mdl-37397062

ABSTRACT

Peripheral extracorporeal membrane oxygenation (ECMO) is one of the most common strategies for cardiogenic shock. ECMO cannulation is associated with an increased risk of complications. We describe a minimally invasive, off-pump technique to provide adequate hemodynamic support and left ventricular unloading. A 54-year-old male with nonischemic cardiomyopathy and severe peripheral vascular disease with cardiogenic shock was initially supported with inotropes and an intra-aortic balloon pump. Despite continued support, he continued to deteriorate, and we escalated to a temporary left ventricular support with a CentriMag, using a transapical ProtekDuo Rapid Deployment cannula via mini left-thoracotomy. This approach provides adequate hemodynamic support, left ventricular unloading and early ambulation. After 9 days, the patient's functional status was improved and was medically optimized. The patient received a left ventricular assist device as destination therapy. He was discharged home, resumed his normal activities and has been doing well for more than 27 months.

3.
Ann Thorac Surg Short Rep ; 1(2): 335-338, 2023 Jun.
Article in English | MEDLINE | ID: mdl-36852006

ABSTRACT

Airway complications are a major cause of morbidity after thoracic transplantation. Airway ischemia, necrosis, and tracheobronchial anastomotic dehiscence are associated with early mortality. We describe a case of tracheal anastomotic dehiscence after en bloc heart-lung transplant complicated by severe acute respiratory syndrome coronavirus 2 infection. Timely surgical management and reconstruction with a bovine pericardial patch and double muscle flap were performed. After 8 months of follow-up, there are no airway complications and normalized allograft function.

7.
J Card Surg ; 35(12): 3631-3633, 2020 Dec.
Article in English | MEDLINE | ID: mdl-33001516

ABSTRACT

Extracorporeal life support (ECLS) is an expanding technology for patients in cardiogenic shock. The majority of patients requiring ECLS can be managed with percutaneous venoarterial (VA) femoral cannulation. Despite sufficient extracorporeal circulatory support, a unclear number of patients develop left ventricular distension which can result in increased wall tension and stress as well as worsening pulmonary edema. Indications to vent the left ventricle can be controversial. When venting is indicated, a number of additional procedures may be considered including inotropic support, intra-aortic balloon pump, impella, balloon atrial septostomy, or placement of a transseptal cannula. We present a unique case of a femoral VA extracorporeal membrane oxygenation as a bridge to transplant with left-sided venting using a Bio-Medicus NextGen cannula (Medtronic) with a transseptal approach.


Subject(s)
Extracorporeal Membrane Oxygenation , Cannula , Drainage , Heart Ventricles/diagnostic imaging , Heart Ventricles/surgery , Humans , Shock, Cardiogenic/therapy
8.
J Card Surg ; 35(8): 2077-2080, 2020 Aug.
Article in English | MEDLINE | ID: mdl-32652726

ABSTRACT

Heart-lung transplant (HLT) is a widely accepted modality for certain patients with advanced and refractory cardiopulmonary disease. Some of these patients are critically ill on the transplant waiting list, and venoarterial extracorporeal membrane oxygenation (VA-ECMO) can be used as a bridge to transplantation. Although the experience with ECMO as a bridge to lung transplant is promising, there is limited evidence to use ECMO as a bridge to HLT. Femoral cannulation remains a concern for ambulation given the risk of bleeding and cannula complications despite studies reporting its safety. We present a case of a 56-year-old male with interstitial lung disease and severe secondary pulmonary hypertension, who was successfully bridged to HLT with ambulatory femoral VA-ECMO.


Subject(s)
Extracorporeal Membrane Oxygenation/methods , Heart-Lung Transplantation , Hypertension, Pulmonary/therapy , Lung Diseases, Interstitial/therapy , Lung Transplantation , Femoral Artery , Humans , Hypertension, Pulmonary/etiology , Lung Diseases, Interstitial/complications , Male , Middle Aged , Severity of Illness Index , Treatment Outcome , Waiting Lists
10.
J Card Surg ; 34(10): 1127-1129, 2019 Oct.
Article in English | MEDLINE | ID: mdl-31374579

ABSTRACT

Cardiac myxomas can be fatal and left ventricular (LV) myxomas with papillary muscle and mitral valve (MV) involvement are rare. The following case is that of a 55-year-old woman who developed signs and symptoms of pulmonary hypertension. Imaging revealed a contractile mass in the LV that was in continuum with the papillary muscles and affected MV function. Her clinical course, radiologic, and hemodynamic findings are discussed. Finally, her surgical extraction technique is described in addition to potential complications encountered.


Subject(s)
Heart Neoplasms/diagnosis , Hypertension, Pulmonary/etiology , Myxoma/diagnosis , Echocardiography , Female , Heart Neoplasms/complications , Heart Neoplasms/surgery , Heart Ventricles , Humans , Hypertension, Pulmonary/diagnosis , Hypertension, Pulmonary/surgery , Magnetic Resonance Imaging, Cine , Middle Aged , Mitral Valve , Myxoma/complications , Myxoma/surgery , Papillary Muscles , Positron-Emission Tomography , Severity of Illness Index , Tomography, X-Ray Computed
SELECTION OF CITATIONS
SEARCH DETAIL
...